Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
GAIN OF FUNCTION ANKH VARIANTS...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
GAIN OF FUNCTION ANKH VARIANTS CAUSE BOTH FAMILIAL AND SPORADIC CALCIUM PYROPHOSPHATE DIHYDRATE CHONDROCALCINOSIS
Bibliographic Details
Main Authors:
Zhang, Y
,
Johnson, K
,
Russell, G
,
Wordsworth, B
,
Carr, A
,
Terkeltaub, R
,
Brown, M
Format:
Journal article
Published:
2004
Holdings
Description
Similar Items
Staff View
Similar Items
ANKH mutations cause both familial and sporadic calcium pyrophosphate dihydrate chondrocalcinosis and increase ANKH transcription/2 translation.
by: Zhang, Y, et al.
Published: (2004)
Association of sporadic chondrocalcinosis with a -4-basepair G-to-A transition in the 5'-untranslated region of ANKH that promotes enhanced expression of ANKH protein and excess generation of extracellular inorganic pyrophosphate.
by: Zhang, Y, et al.
Published: (2005)
Autosomal dominant familial calcium pyrophosphate dihydrate deposition disease is caused by mutation in the transmembrane protein ANKH.
by: Williams, C, et al.
Published: (2002)
Autosomal dominant familial calcium pyrophosphate dihydrate deposition disease (CPPDD) is caused by mutation in the transmembrane protein ANKH.
by: Williams, C, et al.
Published: (2002)
Inorganic pyrophosphate in plasma, urine, and synovial fluid of patients with pyrophosphate arthropathy (chondrocalcinosis or pseudogout).
by: Russell, R, et al.
Published: (1970)
Autosomal dominant familial calcium pyrophosphate dihydrate deposition disease (CPPDD) is caused by mutation in the transmembrane protein ank.
by: Williams, C, et al.
Published: (2002)
THE ROLE OF ANKH IN ANKYLOSING SPONDYLITIS
by: Timms, A, et al.
Published: (2003)
Investigation of the role of ANKH in ankylosing spondylitis.
by: Timms, A, et al.
Published: (2003)
A Phage Display-Identified Short Peptide Capable of Hydrolyzing Calcium Pyrophosphate Crystals—The Etiological Factor of Chondrocalcinosis
by: Radosław W. Piast, et al.
Published: (2021-09-01)
Refinement of the chromosome 5p locus for familial calcium pyrophosphate dihydrate deposition disease.
by: Andrew, L, et al.
Published: (1999)
Investigation of the role of ENPP1 and TNAP genes in chondrocalcinosis.
by: Zhang, Y, et al.
Published: (2007)
Genetics of chondrocalcinosis and related disorders
by: Brown, M, et al.
Published: (2003)
The diagnosis of calcium pyrophosphate dihydrate crystal deposition disease: the good, the bad and… ultrasonography!
by: B. Frediani, et al.
Published: (2012-07-01)
Genetic testing for haemochromatosis in patients with chondrocalcinosis.
by: Timms, A, et al.
Published: (2002)
Lack of genetic association of the ENPP1 and TNAP genes with chondrocalcinosis
by: Zhang, Y, et al.
Published: (2006)
Lumbar Spinal Involvement in Calcium Pyrophosphate Dihydrate Disease: A Systematic Literature Review
by: Ben Tekaya A, et al.
Published: (2022-10-01)
The Role of Calcium Pyrophosphate Dihydrate Deposition in the Postoperative Outcome of Lumbar Spinal Stenosis Patients
by: Thanase Ariyawatkul, et al.
Published: (2019-12-01)
Detection of calcium pyrophosphate dihydrate crystals in knee meniscus by dual-energy computed tomography
by: Hidenori Tanikawa, et al.
Published: (2018-04-01)
Chondrocalcinosis and medial unicompartmental knee arthroplasty
by: Woods, D, et al.
Published: (1995)
Calcium Pyrophosphate Dihydrate Crystals Increase the Granulocyte/Monocyte Progenitor (GMP) and Enhance Granulocyte and Monocyte Differentiation In Vivo
by: Nobuyuki Onai, et al.
Published: (2020-12-01)
Genetic testing for haemochromatosis in patients with chondrocalcinosis (vol 61, pg 745, 2002)
by: Timms, A, et al.
Published: (2003)
Upper Cervical Compression Myelopathy Caused by the Retro-Odontoid Pseudotumor With Degenerative Osteoarthritis and Calcium Pyrophosphate Dihydrate Disease: A Case Report and Literature Review
by: Takashi Yurube, et al.
Published: (2021-12-01)
Calcium Pyrophosphate Deposition Disease of the Temporomandibular Joint*
by: Vasisht Srinivasan, et al.
Published: (2012-09-01)
Linkage of chondrocalcinosis to chromosome 5p15.1-.2 in a large Argentinean pedigree.
by: Williams, C, et al.
Published: (1997)
Bioceramics Based on β-Calcium Pyrophosphate
by: Tatiana Safronova, et al.
Published: (2022-04-01)
THE LOWER PALEOLITHIC INDUSTRY OF ANKHE IN VIETNAM WITH THE SO-CALLED MOVIUS LINE
by: Nguyễn Khắc Sử
Published: (2019-09-01)
Acute Calcium Pyrophosphate Arthritis after Parathyroidectomy
by: Alper Uçkun, et al.
Published: (2017-08-01)
OSTEOPOROSIS IN CALCIUM PYROPHOSPHATE CRYSTAL DEPOSITION DISEASE
by: S A Vladimirov, et al.
Published: (2013-02-01)
Calcium pyrophosphate deposition disease: clinical manifestations
by: M.A. Cimmino, et al.
Published: (2012-01-01)
Prevalence of Chondrocalcinosis in Patients above 50 Years and the Relationship with Osteoarthritis
by: Hadi Karimzadeh, et al.
Published: (2017-01-01)
Age-related features of calcium pyrophosphate deposition disease
by: M. S. Eliseev, et al.
Published: (2019-12-01)
THE CLINICAL MANIFESTATIONS OF CALCIUM PYROPHOSPHATE CRYSTAL DEPOSITION DISEASE
by: F. M. Kudaeva, et al.
Published: (2014-09-01)
Advances in imaging for the assessment of calcium pyrophosphate deposition disease
by: S. Sirotti, et al.
Published: (2022-12-01)
Physiotherapy and Rehabilitation Interventions in the Conservative Treatment of Chondrocalcinosis: A Case Report
by: Bihter Akınoğlu
Published: (2017-09-01)
Is Calcium Oxalate Dihydrate indicative of hypercalciuria in stone patients?
by: M.S. Hesselholt, et al.
Published: (2023-02-01)
The membrane protein ANKH is crucial for bone mechanical performance by mediating cellular export of citrate and ATP.
by: Flora Szeri, et al.
Published: (2020-07-01)
Metabolism of inorganic pyrophosphate (PPi).
by: Russell, R
Published: (1976)
Calcium pyrophosphate deposition disease: historical overview and potential gaps
by: Carlos Pineda, et al.
Published: (2024-04-01)
Recent advances in the therapeutic management of calcium pyrophosphate deposition disease
by: Paraskevi V. Voulgari, et al.
Published: (2024-03-01)
Polydatin Prevents Calcium Pyrophosphate Crystal-Induced Arthritis in Mice
by: Francesca Oliviero, et al.
Published: (2021-03-01)
Prev
Next
Similar Items
ANKH mutations cause both familial and sporadic calcium pyrophosphate dihydrate chondrocalcinosis and increase ANKH transcription/2 translation.
by: Zhang, Y, et al.
Published: (2004)
Association of sporadic chondrocalcinosis with a -4-basepair G-to-A transition in the 5'-untranslated region of ANKH that promotes enhanced expression of ANKH protein and excess generation of extracellular inorganic pyrophosphate.
by: Zhang, Y, et al.
Published: (2005)
Autosomal dominant familial calcium pyrophosphate dihydrate deposition disease is caused by mutation in the transmembrane protein ANKH.
by: Williams, C, et al.
Published: (2002)
Autosomal dominant familial calcium pyrophosphate dihydrate deposition disease (CPPDD) is caused by mutation in the transmembrane protein ANKH.
by: Williams, C, et al.
Published: (2002)
Inorganic pyrophosphate in plasma, urine, and synovial fluid of patients with pyrophosphate arthropathy (chondrocalcinosis or pseudogout).
by: Russell, R, et al.
Published: (1970)
